TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.
01 1Transo-Pharm USA LLC
02 1Biophore India Pharmaceuticals Pvt Ltd
03 1LGM Pharma
04 13D IMAGING DRUG DESIGN AND DEVELOPMENT LLC
05 1Alembic Pharmaceuticals Limited
06 1Apicore LLC
07 1Emcure Pharmaceuticals
08 1Guangzhou Henovcom Biosciences
09 1Guangzhou Tosun Pharmaceutical
10 1Hangzhou Longshine Bio-Tech
11 1MSN Laboratories
12 1Olon S.p.A
13 1Qilu Pharmaceutical
14 1RANBAXY LABORATORIES LIMITED
15 1Sakar Healthcare
16 1ScinoPharm Taiwan, Ltd
17 1Shilpa Medicare
18 1Sionc Pharmaceuticals
19 1Synbias Pharma Limited Liability Company
20 1Viatris
01 4China
02 9India
03 1Italy
04 1Taiwan
05 4U.S.A
06 1Ukraine
01 11Active
02 2Inactive
03 7Blank
01 20Blank
01 20Blank
01 1WC-0082
02 1WC-0110n
03 1WC-0147A3
04 1WC-0226
05 1WC-0273
06 1WC-0349
07 14Blank
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-28
Pay. Date : 2014-03-06
DMF Number : 27901
Submission : 2014-02-05
Status : Active
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-02-14
Pay. Date : 2017-12-19
DMF Number : 27566
Submission : 2014-12-31
Status : Active
Type : II
NDC Package Code : 65129-1278
Start Marketing Date : 2015-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-10-19
Pay. Date : 2015-04-28
DMF Number : 29318
Submission : 2015-09-10
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-24
Pay. Date : 2014-01-24
DMF Number : 27862
Submission : 2014-01-24
Status : Active
Type : II
Date of Issue : 2022-09-02
Valid Till : 2025-05-05
Written Confirmation Number : WC-0349
Address of the Firm :
NDC Package Code : 54893-0028
Start Marketing Date : 2014-01-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-12-21
Pay. Date : 2015-09-23
DMF Number : 29806
Submission : 2015-09-25
Status : Active
Type : II
Date of Issue : 2021-06-11
Valid Till : 2022-07-02
Written Confirmation Number : WC-0147A3
Address of the Firm :
NDC Package Code : 82920-024
Start Marketing Date : 2022-08-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35033
Submission : 2020-11-30
Status : Active
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-02
Written Confirmation Number : WC-0082
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-01-05
Pay. Date : 2015-12-31
DMF Number : 29706
Submission : 2015-08-13
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-10-01
Pay. Date : 2015-09-18
DMF Number : 25633
Submission : 2012-02-15
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-10
Pay. Date : 2014-01-22
DMF Number : 27797
Submission : 2013-12-30
Status : Active
Type : II
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35212
Submission : 2020-10-06
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-08-25
Pay. Date : 2013-01-14
DMF Number : 26635
Submission : 2012-09-27
Status : Active
Type : II
NDC Package Code : 17337-0310
Start Marketing Date : 2014-08-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29372
Submission : 2015-05-11
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29769
Submission : 2015-09-26
Status : Inactive
Type : II
Date of Issue : 2022-07-15
Valid Till : 2025-07-02
Written Confirmation Number : WC-0110n
Address of the Firm :
NDC Package Code : 42973-173
Start Marketing Date : 2011-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2020-07-23
Valid Till : 2023-05-11
Written Confirmation Number : WC-0273
Address of the Firm :
NDC Package Code : 76055-0016
Start Marketing Date : 2019-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Clofarabine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clofarabine, including repackagers and relabelers. The FDA regulates Clofarabine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clofarabine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clofarabine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clofarabine supplier is an individual or a company that provides Clofarabine active pharmaceutical ingredient (API) or Clofarabine finished formulations upon request. The Clofarabine suppliers may include Clofarabine API manufacturers, exporters, distributors and traders.
click here to find a list of Clofarabine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 20 companies offering Clofarabine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?